Ikarian Capital, LLC Longboard Pharmaceuticals, Inc. Transaction History

Ikarian Capital, LLC

  • $573 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
SELL
$18.89 - $26.06 $18.5 Million - $25.5 Million
-979,226 Reduced 99.98%
236 $5,000
Q4 2023

Feb 14, 2024
BUY
$3.68 - $6.5 $1.71 Million - $3.02 Million
465,361 Added 90.52%
979,462 $5.91 Million
Q3 2023

Nov 14, 2023
BUY
$5.49 - $7.49 $54,065 - $73,761
9,848 Added 1.95%
514,101 $2.86 Million
Q2 2023

Aug 14, 2023
BUY
$4.19 - $10.05 $2.11 Million - $5.07 Million
504,253 New
504,253 $3.7 Million

Others Institutions Holding LBPH

# of Institutions
126
Shares Held
34.9M
Call Options Held
28.9K
Put Options Held
13.9K
View Full List

About Longboard Pharmaceuticals, Inc.

LBPH Quotes by TradingView
  • Ticker LBPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 13,586,000
  • Market Cap $815M
  • Description
  • Longboard Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing transformative medicines for neurological diseases. The company's lead product candidate is LP352, which is in a Phase 1b/2a clinical trial for the treatment of seizures associated with developmental and epileptic encephalopathies. Its preclinical ...
More about LBPH
Track This Portfolio

Track Ikarian Capital, LLC Portfolio

Follow Ikarian Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ikarian Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ikarian Capital, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email